BusinessAbeona Announces Top-Line One Year Data from ABO-102 MPS IIIA Trial at ARM’s Cell & Gene Meeting on the MesaBy Nasdaq OMXOct 6, 2017, 12:25 PM UTC
BusinessAbeona Therapeutics and Brammer Bio Announce Collaboration for Commercial Translation of ABO-102By Nasdaq OMXSep 28, 2017, 12:32 PM UTC
